Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss.


Journal

Lancet (London, England)
ISSN: 1474-547X
Titre abrégé: Lancet
Pays: England
ID NLM: 2985213R

Informations de publication

Date de publication:
01 05 2021
Historique:
received: 15 07 2020
revised: 11 02 2021
accepted: 16 02 2021
pubmed: 30 4 2021
medline: 29 5 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

Miscarriage is generally defined as the loss of a pregnancy before viability. An estimated 23 million miscarriages occur every year worldwide, translating to 44 pregnancy losses each minute. The pooled risk of miscarriage is 15·3% (95% CI 12·5-18·7%) of all recognised pregnancies. The population prevalence of women who have had one miscarriage is 10·8% (10·3-11·4%), two miscarriages is 1·9% (1·8-2·1%), and three or more miscarriages is 0·7% (0·5-0·8%). Risk factors for miscarriage include very young or older female age (younger than 20 years and older than 35 years), older male age (older than 40 years), very low or very high body-mass index, Black ethnicity, previous miscarriages, smoking, alcohol, stress, working night shifts, air pollution, and exposure to pesticides. The consequences of miscarriage are both physical, such as bleeding or infection, and psychological. Psychological consequences include increases in the risk of anxiety, depression, post-traumatic stress disorder, and suicide. Miscarriage, and especially recurrent miscarriage, is also a sentinel risk marker for obstetric complications, including preterm birth, fetal growth restriction, placental abruption, and stillbirth in future pregnancies, and a predictor of longer-term health problems, such as cardiovascular disease and venous thromboembolism. The costs of miscarriage affect individuals, health-care systems, and society. The short-term national economic cost of miscarriage is estimated to be £471 million per year in the UK. As recurrent miscarriage is a sentinel marker for various obstetric risks in future pregnancies, women should receive care in preconception and obstetric clinics specialising in patients at high risk. As psychological morbidity is common after pregnancy loss, effective screening instruments and treatment options for mental health consequences of miscarriage need to be available. We recommend that miscarriage data are gathered and reported to facilitate comparison of rates among countries, to accelerate research, and to improve patient care and policy development.

Identifiants

pubmed: 33915094
pii: S0140-6736(21)00682-6
doi: 10.1016/S0140-6736(21)00682-6
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1658-1667

Subventions

Organisme : Wellcome Trust
ID : 212233/Z/18/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Siobhan Quenby (S)

Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick, UK; Tommy's National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK. Electronic address: s.quenby@warwick.ac.uk.

Ioannis D Gallos (ID)

Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Rima K Dhillon-Smith (RK)

Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Marcelina Podesek (M)

Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Mary D Stephenson (MD)

University of Illinois Recurrent Pregnancy Loss Program, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA.

Joanne Fisher (J)

Warwick Clinical Trials Unit, University of Warwick, Warwick, UK.

Jan J Brosens (JJ)

Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick, UK; Tommy's National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Jane Brewin (J)

Tommy's Charity, Laurence Pountney Hill, London, UK.

Rosanna Ramhorst (R)

CONICET, Universidad de Buenos Aires, Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales IQUIBICEN, Buenos Aires, Argentina.

Emma S Lucas (ES)

Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick, UK; Tommy's National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Rajiv C McCoy (RC)

Department of Biology, Johns Hopkins University, Baltimore, MD, USA.

Robert Anderson (R)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Shahd Daher (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Lesley Regan (L)

Tommy's National Centre for Miscarriage Research, Imperial College London, London, UK.

Maya Al-Memar (M)

Tommy's National Centre for Miscarriage Research, Imperial College London, London, UK.

Tom Bourne (T)

Tommy's National Centre for Miscarriage Research, Imperial College London, London, UK.

David A MacIntyre (DA)

Tommy's National Centre for Miscarriage Research, Imperial College London, London, UK.

Raj Rai (R)

Tommy's National Centre for Miscarriage Research, Imperial College London, London, UK.

Ole B Christiansen (OB)

Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital, Aalborg, Denmark.

Mayumi Sugiura-Ogasawara (M)

Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

Joshua Odendaal (J)

Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Warwick, UK; Tommy's National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Adam J Devall (AJ)

Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Phillip R Bennett (PR)

Department of Biology, Johns Hopkins University, Baltimore, MD, USA.

Stavros Petrou (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Arri Coomarasamy (A)

Tommy's National Centre for Miscarriage Research, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH